Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Actelion Pharmaceuticals UK Ltd
BSI Building 13th Floor, 389 Chiswick High Road, Chiswick, London, W4 4AL
Telephone: +44 (0)208 987 3333
Fax: +44 (0)208 987 3322
WWW: http://www.actelion.com
Medical Information Direct Line: +44 (0)845 075 0555 (UK) / +353 (0)1 890 771 648

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 10/01/2012
PIL Zavesca (miglustat) 100 mg hard capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 16/06/2011 and displayed until 10/01/2012
Reasons for adding or updating:
  • Change to date of revision
Updated on 26/07/2010 and displayed until 16/06/2011
Reasons for adding or updating:
  • Change to date of revision
Updated on 09/12/2009 and displayed until 26/07/2010
Reasons for adding or updating:
  • Change to date of revision
Updated on 12/02/2009 and displayed until 09/12/2009
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 26/08/2008 and displayed until 12/02/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • PIL Retired pending re-submission
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to side-effects
Updated on 09/04/2008 and displayed until 26/08/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Correction of spelling/typing errors
Updated on 30/11/2007 and displayed until 09/04/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 28/11/2007 and displayed until 30/11/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 18/02/2004 and displayed until 28/11/2007
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
  miglustat